Blog
RSS FeedPosted by Michael Wonder on 18 Nov 2022
Diabetic accuses PHARMAC of faulty analysis of glucose monitors
17 November 2022 - Insulin-dependent diabetics say PHARMAC's decision to delay funding a potentially life-saving device appears to be based ...
Posted by Michael Wonder on 15 Nov 2022
Expansion of access to MenB vaccine urgently needed
15 November 2022 - Meningococcal B is a rare but very serious disease, causing death and serious long-term disabilities. Even when ...
Posted by Michael Wonder on 10 Nov 2022
Decision to fund long-acting paliperidone for people with schizophrenia and ibrutinib for people with chronic lymphocytic leukaemia
10 November 2022 - PHARMAC is pleased to announce a decision to fund two new medicines. ...
Posted by Michael Wonder on 10 Nov 2022
Decision to fund vedolizumab for inflammatory bowel disease and brentuximab for rare lymphomas
10 November 2022 - PHARMAC is pleased to announce a decision to fund two new treatments: vedolizumab for inflammatory bowel ...
Posted by Michael Wonder on 07 Nov 2022
PHARMAC widens access to pneumococcal vaccine
7 November 2022 - PHARMAC has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (Prevenar ...
Posted by Michael Wonder on 06 Nov 2022
Woman who has to pay $115k for unfunded cancer drug asks: 'What price is a life?'
5 November 2022 - More than anything, Annemarie Hope-Cross wants to live. ...
Posted by Michael Wonder on 06 Nov 2022
Kiwis with rare disorders want faster progress on 'life or death' health strategy
6 November 2022 - For Samantha Lenik, being diagnosed with Pompe disease after seven years of symptoms was a “double-edged ...
Posted by Michael Wonder on 03 Nov 2022
Advocate 'gutted' as PHARMAC reviews blanket funding of child cancer medicines
2 November 2022 - Rule 8.1b of the Pharmaceutical Schedule allows all child cancer medicines to be funded by PHARMAC. ...
Posted by Michael Wonder on 02 Nov 2022
Forget a Christmas miracle - PHARMAC consults on making the ultimate sacrifice
2 November 2022 - Today PHARMAC released a discussion paper titled Funding of Paediatric Cancer Treatments in New Zealand. ...
Posted by Michael Wonder on 31 Oct 2022
New Zealand Pharmaceutical Schedule - 1 November 2022
1 November 2022 - The November 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Oct 2022
The Meningitis Foundation says PHARMAC proposal to partially fund a meningococcal B vaccine will not work
26 October 2022 - Meningitis Foundation says Pharmac must make vaccine available to all young people, not just those in ...
Posted by Michael Wonder on 26 Oct 2022
PHARMAC funds ramipril for people with high blood pressure
26 October 2022 - PHARMAC today has announced the decision to fund ramipril (branded as Tryzan), an angiotensin-converting enzyme (ACE) inhibitor ...
Posted by Michael Wonder on 25 Oct 2022
PHARMAC to consider funding the Meningococcal B vaccine but concerns remain
26 October 2022 - PHARMAC has confirmed it will consider funding the Meningococcal B vaccine, which is a crucial tool ...
Posted by Michael Wonder on 20 Oct 2022
New Zealand, it's time to put Fairness in Focus
20 October 2022 - Medicines New Zealand is today relaunching their digital public awareness platform Fairness in Focus. ...
Posted by Michael Wonder on 14 Oct 2022
Decision to list a range of medical devices supplied by Biotronik
12 October 2022 - PHARMAC is pleased to announce the approval of a listing agreement with Biotronik for the supply ...